Quintiles will double the size of a regional headquarters in Singapore and raise its profile in Asia. “Quintiles is the largest and fastest growing clinical development group in Asia,” said Dennis Gillings, chairman and CEO. “Since entering the region in the 1990s, we have built a strong staff of 2,800 clinical development professionals, representing a total of 23 nationalities, who have worked in more clinical trials and with more investigator sites than any other single organization in Asia.” Here’s the release.

Integrated Clinical Trial Services named David Shearer chief medical officer and VP of clinical operations. He will oversee protocol review and quality assurance in patient recruitment and the education of physicians for the trials. Here’s a release.

Encorium Group amended its letter of intent with Prologue Research. Kai Lindevall, Encorium’s CEO stated, “As a result of the acquisition of Prologue, we believe we will be able to become one of the strongest oncology specialized CROs in the United States and Europe. Our short-to-mid-term strategy is to focus our growth in three main therapeutic areas, namely cardiovascular, vaccines and oncology.” Here’s the release.

Bio-Kinetic Clinical Applications has formed a collaboration with Quintiles. “Our collaboration with Quest Pharm’s Bio-Kinetic provides our clients with the capability to house large cohort studies for cardiac safety monitoring,” said Eddie Caffrey, Quintiles’ head of global Phase I. Here’s the release.

Phase Forward will participate in the 2nd annual World Drug Safety Congress Europe, to be held September 16-19 at the Hilton London Paddington. William Blackwell, director of Phase Forward’s safety group, will chair the plenary session on Wednesday, September 17. He will discuss current quantitative signal detection techniques and review lessons learned from several recent projects integrating quantitative signal detection into broader safety monitoring procedures to deliver consistent, systematic and efficient processes. Here’s the release.

Electronic data capture provider MedNet Solutions was included on the Inc. magazine list of the 5,000 fastest-growing private companies for the second consecutive year. “We’re both proud of our results and humbled by our good fortune and the dedication of our staff,” said Rob Robertson, president and CEO. “Ranking at number 36 in the Minneapolis-St Paul-Bloomington-MN-WI region as a whole is very gratifying.” MedNet claims Genentech, Teva Pharmacetuicals, AztraZeneca, ImClone and Medtronic as customers.

Have a news release? Send it to .